UNSPSC 51142504: Selegiline

This classification denotes a monoamine oxidase inhibitor with the molecular formula C13H17N.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6W731X367Q, chemically known as (-)-(r)-n,alpha-dimethyl-n-2-propynylphenethylamine monohydrochloride but generally known as selegiline hydrochloride, which bears US NIH Compound Identifier 26758. European Medicines Agency schedules Selegiline hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB04347MIG.

Most nations schedule selegiline under HS 29214980 and SITC 51454. As of Q4 2014, SELEGILINE remains the US FDA Preferred Term for this commodity. Selegiline bears US NLM identifiers UMLS ID C0036579 and NCI Concept Code C61938. SMILES: CL.N(C(CC1CCCCC1)C)(CC#C)C.

UNSPSC 51142504 Selegiline, a Commodity code, shows minimal relevant recent activity in state and local procurement. The three opportunities posted under this code in the past year span athletics training services for public safety personnel, first-aid and medical supplies for fire rescue, and a district attorney's office dog — none of which align with selegiline, a medication typically used to treat Parkinson's disease and depression. The mismatch suggests either miscoding in the originating procurement systems or that selegiline is not a material category in state and local government purchasing at this time.

The limited opportunities originate from a mix of issuing bodies: the City of Tucson (Arizona), the City of Tampa (Florida), and Washington County (Oregon). No repeat buyers appear in the recent block. Beyond the geographic distribution of these three jurisdictions, the source provides no broader state or regional activity pattern to characterize. Unless state and local procurement offices begin tagging pharmaceutical and medical supplies correctly under this code, pursuit of opportunities here is not warranted.